Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination

DNA vaccines or proteins are capable of inducing specific immunity; however, the translation to the clinic has generally been problematic, primarily due to the reduced magnitude of immune response and poor pharmacokinetics. Herein we demonstrate a composite microsphere formulation, composed of mesop...

Full description

Bibliographic Details
Main Authors: Ho, J., Huang, Y., Danquah, Michael, Wang, H., Forde, G.
Format: Journal Article
Published: Elsevier Science 2010
Online Access:http://hdl.handle.net/20.500.11937/17451
_version_ 1848749469740302336
author Ho, J.
Huang, Y.
Danquah, Michael
Wang, H.
Forde, G.
author_facet Ho, J.
Huang, Y.
Danquah, Michael
Wang, H.
Forde, G.
author_sort Ho, J.
building Curtin Institutional Repository
collection Online Access
description DNA vaccines or proteins are capable of inducing specific immunity; however, the translation to the clinic has generally been problematic, primarily due to the reduced magnitude of immune response and poor pharmacokinetics. Herein we demonstrate a composite microsphere formulation, composed of mesoporous silica spheres (MPS) and poly(d,l-lactide-co-glycolide) (PLGA), enables the controlled delivery of a prime-boost vaccine via the encapsulation of plasmid DNA (pDNA) and protein in different compartments. Method with modified dual-concentric-feeding needles attached to a 40 kHz ultrasonic atomizer was studied. These needles focus the flow of two different solutions, which passed through the ultrasonic atomizer. The process synthesis parameters, which are important to the scale-up of composite microspheres, were also studied. These parameters include polymer concentration, feed flowrate, and volumetric ratio of polymer and pDNA-PEI/MPS-BSA. This fabrication technique produced composite microspheres with mean D[4,3] ranging from 6 to 34 µm, depending upon the microsphere preparation. The resultant physical morphology of composite microspheres was largely influenced by the volumetric ratio of pDNA-PEI/MPS-BSA to polymer, and this was due to the precipitation of MPS at the surface of the microspheres. The encapsulation efficiencies were predominantly in the range of 93-98% for pDNA and 46-68% for MPS. In the in vitro studies, the pDNA and protein showed different release kinetics in a 40 day time frame. The dual-concentric-feeding in ultrasonic atomization was shown to have excellent reproducibility. It was concluded that this fabrication technique is an effective method to prepare formulations containing a heterologous prime-boost vaccine in a single delivery system. © 2010 Elsevier B.V. All rights reserved.
first_indexed 2025-11-14T07:21:26Z
format Journal Article
id curtin-20.500.11937-17451
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:21:26Z
publishDate 2010
publisher Elsevier Science
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-174512017-09-13T15:44:15Z Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination Ho, J. Huang, Y. Danquah, Michael Wang, H. Forde, G. DNA vaccines or proteins are capable of inducing specific immunity; however, the translation to the clinic has generally been problematic, primarily due to the reduced magnitude of immune response and poor pharmacokinetics. Herein we demonstrate a composite microsphere formulation, composed of mesoporous silica spheres (MPS) and poly(d,l-lactide-co-glycolide) (PLGA), enables the controlled delivery of a prime-boost vaccine via the encapsulation of plasmid DNA (pDNA) and protein in different compartments. Method with modified dual-concentric-feeding needles attached to a 40 kHz ultrasonic atomizer was studied. These needles focus the flow of two different solutions, which passed through the ultrasonic atomizer. The process synthesis parameters, which are important to the scale-up of composite microspheres, were also studied. These parameters include polymer concentration, feed flowrate, and volumetric ratio of polymer and pDNA-PEI/MPS-BSA. This fabrication technique produced composite microspheres with mean D[4,3] ranging from 6 to 34 µm, depending upon the microsphere preparation. The resultant physical morphology of composite microspheres was largely influenced by the volumetric ratio of pDNA-PEI/MPS-BSA to polymer, and this was due to the precipitation of MPS at the surface of the microspheres. The encapsulation efficiencies were predominantly in the range of 93-98% for pDNA and 46-68% for MPS. In the in vitro studies, the pDNA and protein showed different release kinetics in a 40 day time frame. The dual-concentric-feeding in ultrasonic atomization was shown to have excellent reproducibility. It was concluded that this fabrication technique is an effective method to prepare formulations containing a heterologous prime-boost vaccine in a single delivery system. © 2010 Elsevier B.V. All rights reserved. 2010 Journal Article http://hdl.handle.net/20.500.11937/17451 10.1016/j.ejps.2010.01.011 Elsevier Science restricted
spellingShingle Ho, J.
Huang, Y.
Danquah, Michael
Wang, H.
Forde, G.
Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination
title Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination
title_full Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination
title_fullStr Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination
title_full_unstemmed Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination
title_short Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination
title_sort synthesis of biodegradable polymer-mesoporous silica composite microspheres for dna prime-protein boost vaccination
url http://hdl.handle.net/20.500.11937/17451